venlafaxine hydrochloride

Generic: venlafaxine hydrochloride

Labeler: annora pharma private limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine hydrochloride
Labeler annora pharma private limited
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 150 mg/1

Manufacturer
Annora Pharma Private Limited

Identifiers & Regulatory

Product NDC 71785-1008
Product ID 71785-1008_b45cbdea-d1be-c16d-e053-2a95a90a821e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA212277
Listing Expiration 2026-12-31
Marketing Start 2019-07-08

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 717851008
Hyphenated Format 71785-1008

Supplemental Identifiers

RxCUI
313581 313583 313585
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine hydrochloride (source: ndc)
Application Number ANDA212277 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1008-0)
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1008-1)
  • 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1008-2)
  • 10 BLISTER PACK in 1 CARTON (71785-1008-3) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
source: ndc

Packages (4)

Ingredients (1)

venlafaxine hydrochloride (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b45cbdea-d1be-c16d-e053-2a95a90a821e", "openfda": {"unii": ["7D7RX5A8MO"], "rxcui": ["313581", "313583", "313585"], "spl_set_id": ["e901e476-58bd-4204-baaa-a4634ae65ab3"], "manufacturer_name": ["Annora Pharma Private Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1008-0)", "package_ndc": "71785-1008-0", "marketing_start_date": "20190708"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1008-1)", "package_ndc": "71785-1008-1", "marketing_start_date": "20190708"}, {"sample": false, "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1008-2)", "package_ndc": "71785-1008-2", "marketing_start_date": "20190708"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (71785-1008-3)  / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "71785-1008-3", "marketing_start_date": "20190708"}], "brand_name": "VENLAFAXINE HYDROCHLORIDE", "product_id": "71785-1008_b45cbdea-d1be-c16d-e053-2a95a90a821e", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "71785-1008", "generic_name": "VENLAFAXINE HYDROCHLORIDE", "labeler_name": "Annora Pharma Private Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VENLAFAXINE HYDROCHLORIDE", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA212277", "marketing_category": "ANDA", "marketing_start_date": "20190708", "listing_expiration_date": "20261231"}